Use of Virtual Reality Game Playing During Venipuncture

May 13, 2019 updated by: University of California, Davis
To evaluate the impact of using virtual reality, VR, game playing on successful completion and reduction of distress and pain in pediatric venipuncture, and to increase adherence in obtaining the desired blood volume.

Study Overview

Detailed Description

Participants will be randomly assigned using a random number generator to either the virtual reality condition, or to the standard procedure that includes using books and/or watching movies as a standard method of distraction.

Participants will take part in the study during their scheduled research venipuncture. The venipuncture lasts approximately 15-30 minutes. Pre and post venipuncture questionnaires for both participant and parent will take 15 minutes to complete. Total study time is between 30 and 45 minutes. Questionnaires completed by research personal will take 15 minutes to complete.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Sacramento, California, United States, 95817
        • University of California Davis MIND Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 19 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Participants aged 8-19 years old that are receiving a blood draw as part of their ReCHARGE evaluation
  2. History of distress or refusal of blood draws or similar medical procedures OR
  3. Parent or child endorsement of fear, anxiety, concern or adherence in past blood draw during the recruitment phone call, consent or child evaluation will be offered the potential of the VR intervention OR
  4. Endorsement of anxiety or concerns with medical procedures on an in house phlebotomist blood draw screening form will also be used as inclusion criteria.

Exclusion Criteria:

  1. History of seizures.
  2. Vision loss or significant visual impairment to the degree that the participant is unable to see the activity and features of the VR game.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtual Reality Group
Participants may be randomized to the virtual reality, VR, group or the standard of care group. For the VR group, we are using the Samsung VR Go (VR head set), Samsung S7 (phone) and programmed distraction (Spaceburgers, Pebbles the Penguin, and/or Happy Place). Spaceburgers and Pebbles the Penguin were designed by the Department of Anesthesiology at Lucile Packard Children's Hospital Stanford through the Stanford Chariot Program (Childhood Anxiety Reduction Through Innovation and Technology). Happy Place is a nongame immersive experience that will be offered to children uninterested in the previously mentioned game. Happy Place was designed by a Swedish Pharmacy Chain, Apotek Hjartat, aimed to distract patients from their pain with a peaceful, interactive environment. Each of the video games runs for the length of time needed to complete the venipuncture.
Samsung VR Go (VR head set), Samsung S7 (phone), and programmed distraction
Active Comparator: Standard of Care Group
Participants may be randomized to the virtual reality, VR, group or the standard of care group. The standard of care group will use various distractions. Distraction tools include books and movies using a wall mounted TV as standard practice.
Books, movies, TV

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attempting vs. Refusing Venipuncture
Time Frame: 2 years
Compare if the participant is willing to let us attempt the venipuncture or refuses the venipuncture. the number of patients will be counted.
2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood volume
Time Frame: 2 years. Collected once on each participant: immediately following injection
Volume of blood collected in mL
2 years. Collected once on each participant: immediately following injection
Pain Scale
Time Frame: 2 years. Collected once on each participant: immediately following injection
Pain scale measures patient reports of pain levels after venipuncture on scale of 0-10
2 years. Collected once on each participant: immediately following injection
Satisfaction Survey
Time Frame: 2 years. Collected once on each participant: immediately following injection
Child and Parent Satisfaction Survey consists of 5 questions with likert scale responses
2 years. Collected once on each participant: immediately following injection
Fear Scale
Time Frame: 2 years. Collected twice on each participant: before and immediately following injection
Child Fear scale measures patient reports of fear levels before and after venipuncture on scale of 0-4
2 years. Collected twice on each participant: before and immediately following injection
Time to Achieve Optimal Blood Volume
Time Frame: 2 years. Collected on each participant: during venipuncture procedure
Time in minutes
2 years. Collected on each participant: during venipuncture procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 9, 2018

Primary Completion (Actual)

January 15, 2019

Study Completion (Actual)

January 15, 2019

Study Registration Dates

First Submitted

March 27, 2018

First Submitted That Met QC Criteria

May 4, 2018

First Posted (Actual)

May 8, 2018

Study Record Updates

Last Update Posted (Actual)

May 15, 2019

Last Update Submitted That Met QC Criteria

May 13, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 1170355

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism

Clinical Trials on Virtual Reality

3
Subscribe